The METAGENETM technology harnesses hydrogen released from low-cost and low-carbon footprint metallic alloys via hydrolysis, establishing an autonomous, on-demand pressurized energy process
Lab scale pilot tests results help strengthen the patent application before progressing to PCT national phase and reaching 'Patent Pending' status
Patent examiners' offices reports highlights the METAGENETM unique innovation and robustness without any anteriority, which is very rare
The technology simplicity and safety potential attract interest from defence related institutional and industrial partners in Europe who have pre-selected the project for a grant allocation to finance up to 75% of the €1 million cost of manufacturing an Industrial scale pilot plant
The Technology’s key innovation lies in its use of a non-powder-based, non-explosive, and non-hazardous consumable energy source to produce hydrogen. This stands in contrast to traditional processes, which rely on highly explosive fossil fuels or nano- and micro-sized metallic powders as combustibles
In addition to being a Novacium shareholder HPQ holds an exclusive North American (Canada, USA and Mexico) METAGENETM licence
MONTREAL, Nov. 20, 2024 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials, is pleased to update shareholders on the latest hydrogen milestones achieved by its France-based affiliate, NOVACIUM SAS (Novacium).
A disruptive technology
Novacium METAGENETM is an autonomous on demand hydrogen production system using hydrolysis which can generate compressed hydrogen at pressures needed for industrial civilian and military applications.
The Patent Pending technology's key innovation lies in its unique ability to use a bulk, non-explosive, and non-hazardous aluminum silicon-based alloy as the consumable energy source for hydrogen production. This breakthrough addresses the two critical issues highlighted in an August 21, 2021 MIT News Article that have hindered aluminum from being used as a safe and economical hydrogen source: ensuring the aluminum surface remains clean and reactive with water and enabling the use of scrap aluminum from various sources as feedstock, since pure aluminum is energy-intensive to mine and produce.
METAGENETM offers another unique advantage: the process operates without requiring electricity, extensive storage, or complex transportation infrastructure, providing a truly autonomous solution. In contrast, traditional hydrogen production systems, such as electrolysis and steam methane reforming, are capital-intensive, emit significant amounts of carbon, and depend on large quantities of electricity, along with costly storage and complex logistical transportation infrastructures.
Technology validated at lab scale
In July 2022, a lab-scale pilot plant was designed, built, and assembled at Novacium's laboratory. Preliminary tests were conducted over a 10-month period, culminating in the filing of a provisional patent application in May 2023 for a low-carbon-footprint, chemical-based, on-demand, high-pressure autonomous hydrogen production system (HPQ September 7, 2023, release).
Testing continued over the 18 months leading up to the patent's progression to the PCT national phase. During this time, efforts focused on completing the scale-up design for an industrial pilot plant and initiating discussions with potential clients to secure grant financing covering 35% to 75% of the costs required to deliver the first working prototype.
As shown in the image below, the process uses a bulk, non-explosive, and non-hazardous aluminum-silicon-based alloy as the consumable energy source to produce hydrogen. [link to a short video demonstrating the reaction].
Image 1 Lab-scale pilot plant reactor in action_FR-EG
Image 1) Lab-scale pilot plant reactor in action
Very positive research report from patent examiners received prior to entering the PCT national phase
In October 2024, Novacium received a highly commendatory research report from the patent examiner's office reviewing its provisional patent application. The report not only highlighted the unique value proposition of the technology but also stated that no prior art could be identified, making the patent very strong.
“It is rare, in a field as established as hydrolysis, to achieve a true technological breakthrough,” said Dr. Jed Kraiem, Chief Operating Officer of Novacium. “The recognition of our process as unprecedented, with no prior art, demonstrates that it is still possible to push the boundaries of innovation, even in mature fields.”
“For startups like HPQ and Novacium, having a solid intellectual property portfolio is crucial. It not only allows us to protect our technologies but also enhances their value and strengthens our position in the market,” added Dr. Kraiem.
Technology generates strong interest from defence and civilian related partners in Europe
METAGENETM's strategic potential has already drawn significant interest for military applications requiring off grid compressed hydrogen production process from the French Defence Procurement Agency (DGA). As a result, Novacium has been pre-selected by the DGA for funding under the RAPID program, which supports SMEs developing innovative technologies for the French armed forces.
The RAPID program, an acronym for 'Régime d’Appui pour l’Innovation Duale' (Support Scheme for Dual Innovation), is a highly selective program that supports projects with both civil and military applications, enabling companies to develop cutting-edge technical innovations.
This grant financing, representing 75% of the project cost of €1 million, will enable Novacium to accelerate the development phase of its prototype, designed to test high-pressure hydrogen production capabilities under real-world conditions.
The French army, through its Technical Section (STAT), will be the first player to test this technology in real environments. STAT's mission is to evaluate equipment and technological solutions that can meet the operational needs of the land forces, and METAGENETM hydrogen production technology perfectly meets the mobility, safety and reliability requirements required for missions in difficult conditions.
“By providing the armed forces with the means to produce hydrogen on the ground, this innovation could represent a major step forward in achieving energy autonomy for European and North American armed forces. It strengthens their ability to operate independently without relying on conventional energy networks,” said Bernard Tourillon, President and CEO of HPQ Silicon Inc. and NOVACIUM SAS. “With its exclusive license, HPQ is well-positioned to introduce this innovative solution to North American markets.”
About NOVACIUM SAS
Novacium is an HPQ - affiliated company that started in Q3 2022. This green technology startup is based in Lyon, France and is a partnership with HPQ and three of France’s leading research engineers, Dr. Jed KRAIEM PhD, Novacium's Chief Operating Officer (“COO”), Dr. Oleksiy NICHIPORUK PhD, Novacium's Chief Technical Officer (“CTO”), and Dr. Julien DEGOULANGE PhD, Novacium’s Chief Innovation Officer (“CIO”). Novacium is a new Research and Development company which allows researchers to develop their own technology in high-added-value fields connected to renewable energy and allows HPQ Silicon Inc. a Canadian company, to expand the depth and reach of its technical team to help develop its silicon and new renewable energy projects.
HPQ is developing, with the support of world-class technology partners PyroGenesis Canada Inc. and NOVACIUM SAS, new green processes crucial to make the critical materials needed to reach net zero emissions.
HPQ activities are centred around the following four (4) pillars:
1)
Becoming a green low-cost (Capex and Opex) manufacturer of Fumed Silica using the FUMED SILICA REACTOR, a proprietary technology owned by HPQ Silica Polvere Inc being developed for HSPI by PyroGenesis.
2)
Becoming a producer of silicon-based anode materials for battery applications with the assistance of NOVACIUM SAS.
3)
HPQ SILICON affiliate NOVACIUM SAS is developing a low carbon, chemical based on demand and high-pressure autonomous hydrogen production system.
4)
Becoming a zero CO2 low-cost (Capex and Opex) producer of High Purity Silicon (2N+ to 4N) using our PUREVAPTM “Quartz Reduction Reactors” (QRR), a proprietary technology owned by HPQ being developed for HPQ by PyroGenesis.
This press release contains certain forward-looking statements, including, without limitation, statements containing the words "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect", "in the process" and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company's ongoing filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This News Release is available on the company's CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Source: HPQ Silicon Inc.
For further information contact:
Bernard J. Tourillon, Chairman, President, and CEO Tel +1 (514) 846-3271 Patrick Levasseur, Director Tel: +1 (514) 262-9239 Email: Info@hpqsilicon.com
